Post-ASCO Scoreboard Part 2

buy provigil usa Following up on the previous post we can review selected small and mid-stocks participating in the ASCO Conference look at performance over 3 months from March 14 to June 13 including a 7% correction in the market overall. Most biotech stocks peaked in Q2 2011. See previous post for  ASCO news releases. The broad based ETF IBB was up 7.65% over the same 3 mo. period and the NASDAQ was down 2.8%.

click watch ETF (IBB $103)                        Up 7.65%     Peak $110

Ariad  (ARIA $9.64)                    Up 68.8%    Peak $10

Endocyte (ECYT  $11.87)            Up 58.5%    Peak $12.15

Exelixis (EXEL $8.87)                 Down 21%  Peak $12.37

Incyte (INCY $17.45)                   Up 29.4%    Peak $21.15

Onyx (ONXX $36.21)                   Flat               Peak $45

Seattle Genetics(SGEN $19.53) Up 36.1%     Peak  $20

No comments yet.

Leave a Reply